Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 2.803.652 | 616.980 | 1 | ||
2012 | 0 | 6.090.575 | 1.097.115 | 2 | ||
2010 | 0 | 11.999.205 | 667.280 | 1 |
Total number of partners: 41
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 41
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-01-01 | Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria | SYSMALVAC | participant | 2.803.652 | 7 |
2012-11-01 | Best EScalation Treatment in Multiple Sclerosis (MS) | BEST MS | participant | 4.880.575 | 5 |
2012-09-01 | Genes And Proteins for AutoImmunity Diagnostics | GAPAID | participant | 1.210.000 | 10 |
2010-07-01 | NANOTECHNOLOGICAL TOOLKITS FOR MULTI-MODAL DISEASE DIAGNOSTICS AND TREATMENT MONITORING | NAMDIATREAM | participant | 11.999.205 | 23 |